We are live on
!
Find out more
TA
TLS Advisors Portfolio holdings
AUM
$34M
1-Year Est. Return
11.11%
This Fund
S&P 500
This Quarter
Est. Return
+19.06%
1 Year Est. Return
+11.11%
3 Year Est. Return
+36.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.3M
AUM Growth
+$3.87M
(+20%)
Cap. Flow
+$715K
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
97.18%
Holding
18
New
4
Increased
1
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$1.19M |
| 2 |
BHP
BHP
|
+$801K |
| 3 |
Rio Tinto
RIO
|
+$720K |
| 4 |
Greenland Technologies Holding
GTEC
|
+$19K |
| 5 |
XOMA
Xoma
XOMA
|
+$3.75K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLU
BELLUS Health Inc.
BLU
|
+$905K |
| 2 |
OmniAb
OABI
|
+$431K |
| 3 |
LITS
Lite Strategy Inc
LITS
|
+$244K |
| 4 |
Ovid Therapeutics
OVID
|
+$206K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$205K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.32% |
| 2 | Energy | 33.81% |
| 3 | Communication Services | 13.04% |
| 4 | Materials | 11.02% |
| 5 | Consumer Discretionary | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
EQT Corp
EQT
$34.3B
| $6.16M | 26.41% |
150,800
| – | – |
|
|
2
Ovid Therapeutics
OVID
$572M
| $4.33M | 18.57% |
1,319,679
-60,667
| -4% | -$206K |
|
3
Meta Platforms (Facebook)
META
$1.45T
| $3.04M | 13.04% |
10,589
| – | – |
|
|
XOMA
4
DELISTED
Xoma
XOMA
| $2.28M | 9.78% |
120,665
+200
| +0.2% | +$3.75K |
|
5
Range Resources
RRC
$9.73B
| $1.73M | 7.4% |
58,823
-1,000
| -2% | -$27.2K |
|
6
Xenon Pharmaceuticals
XENE
$6B
| $1.3M | 5.58% |
33,756
| – | – |
|
|
7
OmniAb
OABI
$670M
| $1.26M | 5.4% |
250,185
-106,407
| -30% | -$431K |
|
|
8
Vale
VALE
$65.2B
| $1.09M | 4.69% |
+84,000
| New | +$1.19M |
|
|
9
BHP
BHP
$245B
| $780K | 3.35% |
+13,440
| New | +$801K |
|
|
10
Rio Tinto
RIO
$170B
| $695K | 2.98% |
+11,200
| New | +$720K |
|
11
Hovnanian Enterprises
HOV
$743M
| $384K | 1.65% |
3,872
| – | – |
|
12
iShares MSCI Singapore ETF
EWS
$1.23B
| $252K | 1.08% |
13,600
| – | – |
|
|
13
Greenland Technologies Holding
GTEC
$22.3M
| $19K | 0.08% |
+12,054
| New | +$19K |
|
|
NBIS
14
Nebius Group N.V.
NBIS
$59.4B
| $1K | ﹤0.01% |
17,811
| – | – |
|
|
NIRWW
15
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
| $1K | ﹤0.01% |
10,000
| – | – |
|
|
LITS
16
Lite Strategy Inc
LITS
$34M
| – | – |
-53,250
| Closed | -$244K |
|
|
17
Regeneron Pharmaceuticals
REGN
$83.2B
| – | – |
-250
| Closed | -$205K |
|
|
BLU
18
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-125,731
| Closed | -$905K |
|
Similar funds
QC
CPCM
EGI
SL
LWM
RF
MUMSS
CGIM
TLS Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, TLS Advisors held 18 positions worth $23.3M, up 20% from $19.4M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
TLS Advisors deployed $715K of net new capital in Q2 2023, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Vale: 84,000 shares worth $1.09M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 51% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was OmniAb, an estimated $431K trimmed.
- TLS Advisors's largest Q2 2023 buy was Vale: 84,000 shares worth $1.09M.
- TLS Advisors added most to Xoma in Q2 2023, an estimated $3.75K increase.
- TLS Advisors's biggest Q2 2023 reduction was OmniAb, cutting an estimated $431K.
- TLS Advisors fully exited BELLUS Health Inc. in Q2 2023, selling an estimated $905K.
- TLS Advisors's ten largest holdings make up 97% of its $23.3M portfolio in Q2 2023.
- TLS Advisors opened 4 new positions and closed 3 in Q2 2023.
- TLS Advisors's portfolio value rose 20% quarter-over-quarter to $23.3M.
Based on TLS Advisors's 13F filing for Q2 2023, filed 16 Nov 2023.